ORGO

Organogenesis Holdings Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 9/10
  • Value↑ 8/10
Organogenesis Holdings sales and earnings growth
ORGO Growth
Great
  • Revenue Y/Y↑ 17.04%
  • EPS Y/Y↑ 1700.00%
  • FCF Y/Y↓ -685.73%
Organogenesis Holdings gross and profit margin trends
ORGO Profitability
Good
  • Gross margin ↑ 75.60%
  • EPS margin↓ 3.50%
  • ROIC 5Y↓ 0.95%
Organogenesis Holdings net debt vs free cash flow
ORGO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 19.6

Organogenesis Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗